Articles in this Section
| << Deal Trackers | Distribution & Marketing (63 articles) |
Editorial >> |
| << Previous | Next >> |
-
Elan Streamlines CNS Portfolio with Divestment of Two Drugs
-
Mayne to Market Paxene® in the EU
-
Shire’s Exit Strategy from Japan Provides Bayer with Exclusive Product Rights
-
Yamanouchi to Market Aventis’ Peptic Ulcer Drug Amidst Merger Talks
-
SkyePharma License Marketing and Distribution Rights for DepoCyte® to Mundipharma
-
OSI Gains US Marketing Rights for Gelclair™ from Celgene
-
Bayer Buys Marketing Rights to GW Pharmaceuticals’ Cannabis-Based Treatment
-
Artus Partners with Abbott Laboratories to Market SARS Diagnostic Test
-
Novo Nordisk and Fournier Pharma Sign Co-Marketing Agreement for Repaglinide in Europe
-
Eyetech Pharmaceuticals Enters Deal to Market Pfizer’s Xalatan®



RSS